BioCryst
Trade BioCryst 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
BCRX Key Statistics
Stock Snapshot
With a market cap of 2.18B, BioCryst(BCRX) trades at $8.56. The stock has a price-to-earnings ratio of -4.83.
On 2026-05-12, BioCryst(BCRX) stock moved within a range of $8.50 to $8.80. With shares now at $8.56, the stock is trading +0.7% above its intraday low and -2.7% below the session's peak.
Trading activity shows a volume of 3.71M, compared to an average daily volume of 4.31M.
The stock's 52-week range extends from a low of $6.00 to a high of $11.31.
The stock's 52-week range extends from a low of $6.00 to a high of $11.31.
BCRX News
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported upbeat earnings for the first quarter on Wednesday. The company posted quarterly earnings of 14 cents per s...
Citizens analyst Jonathan Wolleben raised the firm’s price target on BioCryst (BCRX) to $28 from $25 and keeps an Outperform rating on the shares. Orladeyo post...
BioCryst Pharmaceuticals ((BCRX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level dat...
Analyst ratings
100%
of 11 ratingsMore BCRX News
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
On 4 May 2026, BioCryst Pharmaceuticals announced it had licensed European commercialization rights for its investigational HAE therapy navenibart to an Irish a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.